| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.2 | 0.0004 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.14 | 0.02 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.11 | 0.05 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.11 | 0.06 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.093 | 0.09 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.083 | 0.2 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.07 | 0.2 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.068 | 0.3 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.058 | 0.3 |